Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

Kaiser Daily Global Health Policy ReportPrivate Sector Involvement Search Results « » The Henry J. Kaiser Family Foundation

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
China To Receive Discounts On GSK’s New HIV Drug Under Manufacturing Deal

Reuters: Manufacturing deal wins China cheap supply of GSK’s new HIV drug “China will receive cut-price supplies of GlaxoSmithKline’s new HIV drug Tivicay, following a deal for Shanghai-based Desano Pharmaceuticals to become an additional manufacturer of the medicine’s active ingredient. The collaboration between GSK’s HIV unit ViiV Healthcare and Desano…

2 U.S. Oil Companies, Equatorial Guinea Partner To Fund Malaria Vaccine Trials

Financial Times: Hopes rise for malaria vaccine as oil companies fund trials “Two U.S. oil companies are pouring millions of dollars into the trials of a promising malaria vaccine in Equatorial Guinea in a rare sign of foreign investors trying to help tackle one of Africa’s biggest health scourges. Marathon…

China Rejects Patent Application For Gilead’s Hepatitis C Drug

Reuters: China rejects patent linked to Gilead hepatitis C drug “China has rejected a Gilead Sciences Inc. patent application related to its costly hepatitis C drug, a U.S. advocacy group said, adding the move may lead to other countries to consider rejecting patents for the controversial treatment…”

Liberia Launches Study To Assess Ebola’s Long-Term Health Effects; Drugmakers Struggle To Assess Ebola Vaccines In Clinical Trials Due To Lack Of Qualified Volunteers

Agence France-Presse: Thousands of Liberians in ‘post-Ebola syndrome’ study “Liberia launched a five-year study on Wednesday to unravel the mystery of the long-term health effects that plague Ebola survivors and assess how long they should go without sex…” (Dosso, 6/17). Reuters: Ebola vaccines in limbo expose need for more speed…

NEJM Perspective Piece Examines TPP’s Potential Impact On Health Policy Issues

New England Journal of Medicine: The Trans-Pacific Partnership — Is It Bad for Your Health? Amy Kapczynski, professor of law at Yale Law School and faculty director of the Global Health Justice Partnership “International trade deals once focused primarily on tariffs. As a result, they had little direct effect on…

Focus On Better Management, Deployment Of Existing, New Drugs Instead Of Cost

The Hill: New approach needed in fight against deadly diseases Roger Bate, scholar at the American Enterprise Institute “…Constant focus on drug pricing and criticism of lack of access can discourage developers from investing in new treatments. … TB and malaria are being combated in poor countries, but drug resistance…